About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Who Should or Shouldn't Take Aspirin to Tackle Heart Attacks Found

by Dr. Enozia Vakil on May 10, 2014 at 2:36 PM
Font : A-A+

 Who Should or Shouldn't Take Aspirin to Tackle Heart Attacks Found

Washington, May 10 (ANI): Despite aspirin being known to prevent heart attacks and strokes for over 30 years, a new study suggests that it is still unclear as to who exactly should take it daily.

The research shows that your coronary artery calcium (CAC) score, a measurement of plaque in the arteries that feed the heart, may help determine whether or not you are a good candidate for aspirin.

Advertisement

"Many heart attacks and strokes occur in individuals who do not appear to be at high risk," lead author, Michael D Miedema, MD, MPH said.

"Individuals with known CVD [cardiovascular disease] should take a daily aspirin, but the best approach for individuals without known CVD is unclear." If we only treat high-risk individuals with aspirin, we are going to miss a substantial portion of patients who eventually suffer heart attacks.
Advertisement

"However, liberally prescribing aspirin increases the bleeding risk for a significant number of people who were never going to have a heart attack in the first place. With this study, we wanted to see if there is potentially a better way to determine who to treat with aspirin beyond simply using traditional risk factors," he added.

Aspirin helps prevent heart attacks and strokes by preventing blood clots from forming in arteries lined with unhealthy plaque buildup.

However, this same benefit puts patients taking aspirin at risk for dangerous bleeding, when blood clots don't form where they should.

For that reason, the American Heart Association (AHA) guidelines currently recommend aspirin to prevent cardiovascular disease (CVD) in people who have known CVD or who are considered to be at high risk for a CVD event. Aspirin is generally not recommended for people who are considered to be at low or intermediate risk.

The study is published in the journal Circulation: Cardiovascular Quality and Outcomes.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Liver Transplantation
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Amoebic Dysentery Chemotherapy Chemotherapy Drugs Heart Healthy Heart Statins Mitral Valve Prolapse Aortic Valve Stenosis Anticoagulants Healthy Living 

Most Popular on Medindia

Drug Side Effects Calculator Accident and Trauma Care Vent Forte (Theophylline) How to Reduce School Bag Weight - Simple Tips Nutam (400mg) (Piracetam) Turmeric Powder - Health Benefits, Uses & Side Effects Blood - Sugar Chart Drug Interaction Checker Color Blindness Calculator Blood Donation - Recipients
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use